Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 3/20 | 0.51 |
| ▸ | MMP9 | P14780 | 3/20 | 0.51 |
| ▸ | MMP3 | P08254 | 2/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mephobarbital SCHEMBL35624 | 1.00 | LMNA (1.00) | LMNACYP2C19KMT2ATSHRMEN1 | |
| (R)-Methylphenobarbital SCHEMBL11789851 | 1.00 | LMNA (1.00) | LMNACYP2C19KMT2ATSHRMEN1 | |
| Mephobarbital SCHEMBL28475568 | 0.98 | LMNA (0.97) | LMNACYP2C19KMT2ATSHRMEN1 | |
| Mephobarbital SCHEMBL29694125 | 0.98 | LMNA (0.97) | LMNACYP2C19KMT2ATSHRMEN1 | |
| Mephobarbital SCHEMBL7777123 | 0.94 | LMNA (0.88) | LMNACYP2C19KMT2ATSHRMEN1 | |
| Mephobarbital SCHEMBL1004749 | 0.93 | LMNA (0.86) | LMNACYP2C19KMT2ATSHRMEN1 | |
| Mephobarbital SCHEMBL17416929 | 0.91 | LMNA (0.83) | LMNACYP2C19KMT2ATSHRMEN1 | |
| SCHEMBL29402420 | 0.87 | LMNA (0.77) | LMNACYP2C19KMT2ATSHRMEN1 | |
| SCHEMBL5494690 | 0.85 | LMNA (0.73) | LMNACYP2C19KMT2ATSHRMEN1 | |
| SCHEMBL29819552 | 0.84 | LMNA (0.73) | LMNACYP2C19KMT2ATSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10643 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4622640-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | Brightseed, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250281451-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | BRIGHTSEED, INC. | 2025-09-11 | — | — | US | claimed |
| EP-3441087-B1 | METHODS OF TREATING CHRONIC PAIN | TEVA PHARMACEUTICALS INT GMBH (CH) | 2025-02-19 | — | — | EP | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| WO-2024150170-A1 | PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | WO | claimed |
| US-20240238250-A1 | METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2024-07-18 | — | — | US | claimed |
| WO-2024112947-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | BRIGHTSEED, INC. (US) | 2024-05-30 | — | — | WO | claimed |
| WO-2023055939-A9 | APPARATUS, SYSTEMS AND METHODS FOR TRANSDERMAL DRUG DELIVERY, PERMEABILITY ENHANCEMENT AND AUGMENTATION | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2024-04-25 | — | — | WO | claimed |
| US-11858909-B2 | Deuterated etoricoxib, methods of manufacture, and use thereof | Tremeau Pharmaceuticals, Inc. (US) | 2024-01-02 | — | — | US | claimed |
| EP-0566289-A1 | Analysis of hemoglobin variants by capillary electrophoresis | BECKMAN INSTRUMENTS, INC. (US) | 1993-10-20 | — | — | EP | claimed |
| US-5202006-A | Using barbituric acid buffer | BECKMAN INSTRUMENTS, INC. (US) | 1993-04-13 | — | — | US | claimed |
| US-5192550-A | Dosage form for treating central nervous system disorders | ALZA CORPORATION (US) | 1993-03-09 | — | — | US | claimed |
| EP-0308473-A1 | INFRARED IMMUNOLOGICAL DOSING | CNRS, Centre National de la Recherche Scientifique (FR) | 1989-03-29 | — | — | EP | claimed |
| WO-1988007684-A2 | INFRARED IMMUNOLOGICAL DOSING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1988-10-06 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4458044-A | PREVENTION OF FORMATION OF WATER TREES | SIEMENS AKTIENGESELLSCHAFT (DE) | 1984-07-03 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |
| US-3995021-A | DIAZOTIZATION OF AN AMINO PHENYL SUBSTITUTED HAPTEN | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1976-11-30 | — | — | US | claimed |